Delivery Order SPE2DR25D2206-SPE2DR26F9FB8
- Not listed
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,597.56 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, non-set-aside contract will be completed by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills pharmaceutical...
- The Defense Logistics Agency awarded a $10,525.48 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitive award utilizes a firm fixed-price contract structure with a completion date of December 3, 2025, and involves performance at the vendor's facility in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating it was competed among qualified vendors in the open market. This delivery order...
- The Defense Logistics Agency awarded a $3,816.36 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 200 mg/10 mL vials on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-competitive, firm fixed-price delivery order represents a single-line pharmaceutical procurement executed under a competitive award mechanism. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $8,243.54 delivery order to AmerisourceBergen Drug Corp for 4,569,930,973 units of Actemra 400 mg/20 ml vials. This is a non-set-aside, competitively awarded firm fixed-price delivery order with a completion date of November 6, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $77,052.87 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support to federal healthcare...
- AmerisourceBergen Drug Corp was awarded a $8,686.06 delivery order by the Defense Logistics Agency on December 11, 2025, for the supply of Actemra 400 mg/20 ml vials. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by December 12, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,736.36 for Actemra 162 mg/0.9 mL syringes on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price contract, which was not set aside for any socioeconomic category, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $20,188.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 22, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a delivery order valued at $3,386.42 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Actemra 400 mg/20 ml vials. This firm fixed-price delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9FB8Delivery Order
The Defense Logistics Agency awarded a $39,176.41 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The underlying IDC encompasses specialty medications, drugs, vaccines, and other medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The DLA is planning future Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.2k | 12/8/25 |